AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $33.76 million. The enterprise value is -$59.66 million.
| Market Cap | 33.76M |
| Enterprise Value | -59.66M |
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANTX has 29.88 million shares outstanding. The number of shares has increased by 41.95% in one year.
| Current Share Class | 29.88M |
| Shares Outstanding | 29.88M |
| Shares Change (YoY) | +41.95% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 6.46% |
| Owned by Institutions (%) | 18.64% |
| Float | 18.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.75
| Current Ratio | 9.75 |
| Quick Ratio | 9.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.56% and return on invested capital (ROIC) is -35.72%.
| Return on Equity (ROE) | -53.56% |
| Return on Assets (ROA) | -32.19% |
| Return on Invested Capital (ROIC) | -35.72% |
| Return on Capital Employed (ROCE) | -73.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.48M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.46% in the last 52 weeks. The beta is 0.14, so ANTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -69.46% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 1.56 |
| Relative Strength Index (RSI) | 44.19 |
| Average Volume (20 Days) | 149,785 |
Short Selling Information
The latest short interest is 58,838, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 58,838 |
| Short Previous Month | 78,586 |
| Short % of Shares Out | 0.20% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 0.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -64.76M |
| Pretax Income | -66.03M |
| Net Income | -60.70M |
| EBITDA | n/a |
| EBIT | -64.76M |
| Earnings Per Share (EPS) | -$2.04 |
Balance Sheet
| Cash & Cash Equivalents | 93.43M |
| Total Debt | n/a |
| Net Cash | 93.43M |
| Net Cash Per Share | $3.13 |
| Equity (Book Value) | 87.67M |
| Book Value Per Share | 2.94 |
| Working Capital | 87.67M |
Cash Flow
| Operating Cash Flow | -61.05M |
| Capital Expenditures | n/a |
| Free Cash Flow | -61.05M |
| FCF Per Share | -$2.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.95% |
| Shareholder Yield | -41.95% |
| Earnings Yield | -179.77% |
| FCF Yield | -180.82% |
Analyst Forecast
The average price target for ANTX is $3.50, which is 209.74% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.50 |
| Price Target Difference | 209.74% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -10.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |